Nguyen, Christine T.
Chávez-Madero, Carolina
Jacques, Erik
Musgrave, Brennen
Yin, Ting
Saraci, Kejzi
Gilbert, Penney M.
Stewart, Bryan A. http://orcid.org/0000-0003-2520-3632
Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-168932)
Ontario Institute for Regenerative Medicine (2018-0510)
Canada First Research Excellence Fund (MbDC2-2019-02)
Canada Excellence Research Chairs, Government of Canada (950–231201)
Article History
Received: 27 July 2023
Accepted: 10 January 2024
First Online: 8 February 2024
Declarations
:
: Two human immortalized myoblast cell lines (AB1167 and AB1071) used in this study were obtained from the Institut de Myologie in Paris, France, through a material transfer agreement. Donations are collected and distributed under the ethics approval of the Pitié-Salpêtrière Hospital and the Ministry of Higher Education and Research, France. The Institut de Myologie obtains consent and maintains donor anonymity. iPSC cells used were from Alstem, catalogue number IPS11.
: The authors declare no competing interests.